# EDGAR Filing Document

**Accession Number:** 0002107059
**File Stem:** 0001104659-26-046494
**Filing Date:** 2026-4
**Character Count:** 14439
**Document Hash:** 4e7b0e4f4ba4d544ec09d120028be78b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-046494.hdr.sgml**: 20260422

**ACCESSION NUMBER**: 0001104659-26-046494

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260422

**DATE AS OF CHANGE**: 20260422

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Celularity Inc
- **CENTRAL INDEX KEY:** 0001752828
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 831702591
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91021
- **FILM NUMBER:** 26881689

**BUSINESS ADDRESS:**
- **STREET 1:** 170 PARK AVE
- **CITY:** FLORHAM PARK
- **STATE:** NJ
- **ZIP:** 07932
- **BUSINESS PHONE:** (908) 768-2170

**MAIL ADDRESS:**
- **STREET 1:** 170 PARK AVE
- **CITY:** FLORHAM PARK
- **STATE:** NJ
- **ZIP:** 07932

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GX Acquisition Corp.
- **DATE OF NAME CHANGE:** 20180912
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Philip & Daniele Barach Family Trust
- **CENTRAL INDEX KEY:** 0002107059

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 434 SURFVIEW DRIVE
- **CITY:** PACIFIC PALISADES
- **STATE:** CA
- **ZIP:** 90272
- **BUSINESS PHONE:** (818) 694-0182

**MAIL ADDRESS:**
- **STREET 1:** 434 SURFVIEW DRIVE
- **CITY:** PACIFIC PALISADES
- **STATE:** CA
- **ZIP:** 90272

## Exhibit 99.1

**EXHIBIT 1**

**JOINT FILING AGREEMENT**

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that the Amendment No. 1 to Schedule 13D to which this Joint Filing Agreement is being filed as an exhibit shall be a joint statement filed on behalf of each of the undersigned.

---

| | | |
|:---|:---|:---|
| Date: April 22, 2026 |  |  |
|  | **PHILIP & DANIELE BARACH FAMILY TRUST** | **PHILIP & DANIELE BARACH FAMILY TRUST** |
|  | By: | */s/ Philip A. Barach* |
|  | Philip A. Barach, as Trustee of the Philip & Daniele Barach Family Trust | Philip A. Barach, as Trustee of the Philip & Daniele Barach Family Trust |
|  |  | /s/ Philip A. Barach |
|  |  | &nbsp;&nbsp;&nbsp;Philip A. Barach |
|  |  | /s/ Daniele Barach |
|  |  | &nbsp;&nbsp;&nbsp;Daniele Barach |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Celularity Inc.**

*(Name of Issuer)*

**Class A Common Stock, Par Value $0.0001 Per Share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Philip & Daniele Barach Family**<br>Philip A. Barach, Daniele Barach<br>434 Surfview Drive<br>Pacific Palisades CA 90272<br>(818) 694-0182

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/20/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**PHILIP & DANIELE BARACH FAMILY TRUST** | Name of reporting person<br>**PHILIP & DANIELE BARACH FAMILY TRUST** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CALIFORNIA** | Citizenship or place of organization<br>**CALIFORNIA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7558665.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7558665.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.1%** | Percent of class represented by amount in Row (11)<br>**20.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**PHILIP A. BARACH** | Name of reporting person<br>**PHILIP A. BARACH** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CALIFORNIA** | Citizenship or place of organization<br>**CALIFORNIA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7558665.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7558665.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.1%** | Percent of class represented by amount in Row (11)<br>**20.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**DANIELE BARACH** | Name of reporting person<br>**DANIELE BARACH** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CALIFORNIA** | Citizenship or place of organization<br>**CALIFORNIA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7558665.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7558665.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | Aggregate amount beneficially owned by each reporting person<br>**7558665.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.1%** | Percent of class represented by amount in Row (11)<br>**20.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock, Par Value $0.0001 Per Share

**(b) Name of Issuer:**
Celularity Inc.

**(c) Address of Issuer's Principal Executive Offices:**
170 Park Ave, Florham Park, NJ, 07932

This Amendment No. 1 (this "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on April 3, 2026 (the "Original Schedule 13D") by Philip & Daniele Barach Family Trust (the "Trust"), Philip A. Barach and Daniele Barach (each, a "Reporting Person" and collectively, the "Reporting Persons") relating to the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of Celularity Inc. (the "Company"). Except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. Capitalized terms used herein without definition have the meanings ascribed to them in the Original Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information contained on the cover pages to this Amendment and the information set forth or incorporated in Items 2, 4 and 6 of the Original Schedule 13D and Item 3 of this Amendment are incorporated herein by reference. Each of the Reporting Persons beneficially owns 7,558,665 shares of Class A Common Stock, which number includes (i) 3,012,048 shares of Class A Common Stock issuable upon the conversion of $5,000,000 in aggregate principal amount of Convertible Notes (including $2,000,000 in Additional Convertible Notes that the Trust has the present, discretionary right to purchase under the Convertible Note Purchase Agreement) at a conversion price of $1.66 per share, and (ii) 4,546,617 shares of Class A Common Stock issuable upon the exercise of all Warrants at an exercise price of $2.00 per share (including 839,160 shares issuable upon the exercise of additional Warrants that the Company is contractually obligated to issue to the Trust upon the Trust's purchase of Additional Convertible Notes). The shares described in clauses (i) and (ii) are deemed beneficially owned by the Reporting Persons pursuant to Rule 13d-3(d)(1)(i) under the Securities Exchange Act of 1934, as amended, because the Trust has the right to acquire beneficial ownership of such shares within 60 days of April 20, 2026, through a chain of rights entirely within the Trust's control, including (a) the Trust's discretionary right to purchase the Additional Convertible Notes at any time under the Convertible Note Purchase Agreement, (b) the Company's contractual obligation to issue the additional Warrants upon such purchase, (c) the Trust's right to convert all Convertible Notes into shares of Class A Common Stock at any time and (d) the exercisability of all Warrants beginning on June 19, 2026, which is within 60 days of April 20, 2026. The shares of Class A Common Stock beneficially owned by the Reporting Persons represents 20.1% of the shares of Class A Common Stock issued and outstanding, which calculation is based on 28,478,880 shares of Class A Common Stock of the Company issued and outstanding as of December 19, 2025, which was the date of the closing of the Financing.   Each of Mr. Barach and Ms. Barach disclaims beneficial ownership of the shares of Class A Common Stock owned by the Trust, except to the extent of their pecuniary interest therein.

**(b)**
The information contained on the cover pages to this Amendment and the information set forth or incorporated in Items 2, 4 and 6 of the Original Schedule 13D and Item 3 of this Amendment are incorporated herein by reference. None of the Reporting Persons has the sole power to vote or to direct the vote, or the sole power to dispose or to direct the disposition of, any of the shares of Class A Common Stock owned by such Reporting Person.  Each Reporting Person shares with the other Reporting Persons the power to vote or to direct the vote, or the power to dispose or to direct the disposition of, all 7,558,665 shares of Class A Common Stock owned by the Reporting Persons.

**(c)**
None of the Reporting Persons had any transactions in the Class A Common Stock (or securities convertible into or exercisable for shares of Class A Common Stock) during the past 60 days, except as described and referenced in Item 3 of this Amendment. There have been no acquisitions or dispositions of Class A Common Stock by the Reporting Persons since December 19, 2025, other than the Financing described in Item 3.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** PHILIP & DANIELE BARACH FAMILY TRUST

**Signature:** /s/ Philip A. Barach

**Name/Title:** Philip A. Barach, Trustee of the Trust

**Date:** 04/22/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** PHILIP A. BARACH

**Signature:** /s/ Philip A. Barach

**Name/Title:** Philip A. Barach

**Date:** 04/22/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** DANIELE BARACH

**Signature:** /s/ Daniele Barach

**Name/Title:** Daniele Barach

**Date:** 04/22/2026